Early vs Late Dinner for Obesity
(DTOP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how dinner timing affects weight and metabolism. Researchers are particularly interested in whether eating earlier or later in the evening influences body weight and metabolic health. Participants will try both an early dinner (known as Time-Restricted Eating or Early Time-Restricted Feeding) and a late dinner to observe how these changes impact fat processing in the body. Ideal candidates are healthy adults with a normal weight, no sleep disorders, and no significant recent weight changes. As an unphased trial, this study allows participants to contribute to groundbreaking research on diet and metabolism.
Will I have to stop taking my current medications?
Yes, you may need to stop taking certain medications. The trial excludes participants taking prescription medications or drugs that may influence metabolism, such as diet/weight-loss medication, asthma medication, blood pressure medication, psychiatric medications, and others. It's best to discuss your specific medications with the study team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that having dinner earlier can safely and effectively aid weight loss and improve overall health in people with obesity. Time-restricted eating (TRE), which involves consuming meals earlier in the day, has helped individuals lose 1% to 4% of their body weight over several weeks. It also boosts fat burning and improves insulin levels, aiding in blood sugar control.
In contrast, studies suggest that eating dinner late might not be as beneficial. Late dinners can impair sugar processing during sleep and may reduce fat burning, increasing hunger and potentially leading to weight gain and other health issues over time.
While both early and late dinner timings are generally safe, early dinners have demonstrated more positive effects on metabolism and weight management.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how the timing of dinner can influence obesity, a fresh approach compared to traditional methods like diet changes or medication. This study looks at how eating earlier or later affects fat burning in the body, using a special tracer to track fat oxidation. By understanding these effects, scientists hope to uncover new strategies for managing obesity that are simple and lifestyle-based, potentially offering a more natural and sustainable option for weight control.
What evidence suggests that this trial's treatments could be effective for obesity?
This trial will compare the effects of eating dinner at different times on obesity. Research has shown that eating dinner earlier can aid weight loss and improve overall health. Studies have found that people who eat dinner early can lose 1% to 4% of their body weight in just a few weeks. This habit also helps burn fat and lower blood pressure. Conversely, eating dinner late is linked to poorer metabolism, such as higher blood sugar levels and reduced fat burning at night. Late dinners can also increase hunger and the risk of weight gain. Overall, aligning dinner with the body's natural schedule seems to support better health. Participants in this trial will follow both early and late dinner schedules to assess these effects.46789
Who Is on the Research Team?
Jonathan Jun, MD
Principal Investigator
Johns Hopkins University
Stephanie T Chung, MBBS
Principal Investigator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Are You a Good Fit for This Trial?
Adults aged 18-50 with obesity and prediabetes (BMI ≥30 kg/m2) or healthy subjects with a BMI of 18-24.9 can join this study. Participants must understand the procedures, not have metabolic disorders, gastrointestinal surgeries, severe sleep issues, or be on certain medications that affect metabolism.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Circadian Phenotyping
Participants undergo circadian phenotyping with assessment of DLMO, core body temperature profile, and wrist actigraphy
Treatment
Participants are randomized to early or late dinner conditions in a 24-hour metabolic chamber protocol, with a crossover design and a 3- to 4-week washout period
Follow-up
Participants are monitored for metabolic outcomes such as glucose and fat oxidation levels
What Are the Treatments Tested in This Trial?
Interventions
- Early Dinner
- Early Dinner tracer
- Late Dinner
- Late Dinner tracer
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator